dr. scherber discusses ruxolitinib failure in myelofibrosis
Published 5 years ago • 360 plays • Length 2:22Download video MP4
Download video MP3
Similar videos
-
1:48
dr. scherber on the treatment of myelofibrosis
-
2:10
management of ruxolitinib failure in myelofibrosis
-
1:10
dr. bradley on the utility of ruxolitinib in myelofibrosis and polycythemia vera
-
1:46
dr. snyder on ruxolitinib in patients with myelofibrosis
-
1:24
dr. mesa on current data with ruxolitinib and fedratinib in myelofibrosis
-
8:38
the use of ruxolitinib in myelofibrosis
-
1:14
discussing options for ruxolitinib-refractory patients with myelofibrosis
-
9:29
ruxolitinib’s role in treating myelofibrosis
-
1:27
dr. kuykendall on choosing ruxolitinib or fedratinib in myelofibrosis
-
1:12
dr. mesa on the differences between fedratinib and ruxolitinib in myelofibrosis
-
0:50
dr. snyder on how ruxolitinib and fedratinib may pave the way to transplant in myelofibrosis
-
1:02
dr. kremyanskaya on unmet needs in myelofibrosis
-
1:47
dr. oh on the development of jak inhibitors in myelofibrosis
-
2:03
dr. mesa on jakarta-2 reanalysis for myelofibrosis
-
2:54
ruxolitinib in the real world: myelofibrosis
-
0:52
maureen e. thyne discusses ruxolitinib's impact on myelofibrosis
-
1:18
dr. ruben mesa discusses the comfort ruxolitinib trials
-
1:27
real-world use of fedratinib in patients with mf who have failed on ruxolitinib
-
1:14
dr. mesa on the safety profiles of jak inhibitors in myelofibrosis